Michael Kostelansky is a Senior Director of Scientific Licensing and Business Development in Oncology at Bayer, a position held since 2024. They previously served as a Senior Consultant at Easton Associates from 2007 to 2012, and held various roles at Daiichi Sankyo, Inc. and Pfizer, culminating in Director-level positions focused on business analytics and commercial strategy. Additionally, Michael was a PRAT Fellow at NIH, NIDDK from 2004 to 2007. They earned an A.B. in Chemistry from Franklin & Marshall College and a Ph.D. in Chemistry from the University of North Carolina at Chapel Hill.
This person is not in any teams
This person is not in any offices